A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue

A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue

Efforts to control SARS-CoV-2 have been challenged by the emergence of variant strains that have important implications for clinical and epidemiological decision making. Four variants of concern (VOCs) have been designated by the Centers for Disease Control and Prevention (CDC), namely, B.1.617.2 (d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rama Devudu Puligedda, Fetweh H. Al-Saleem, Cristoph Wirblich, Chandana Devi Kattala, Marko Jović, Laura Geiszler, Himani Devabhaktuni, Giora Z. Feuerstein, Matthias J. Schnell, Markus Sack, Lawrence L. Livornese, Scott K. Dessain
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
SARS-CoV-2
delta variant
variants of concern
clinical diagnostic test
monoclonal antibody
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/6bd2a325f0474cec98fd45389e41d35c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares